ALLO Announces FDA Clearance of the IND for ALLO-501 롱

Allogene Therapeutics, Inc.NASDAQ

설명

⋅ 2019년 1월 28일 오후 4시 56분

ALLO: Allogene Therapeutics, Inc.
2019-01-28 08:30:00
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy

Beyond Technical Analysis

코멘트

BasedDeptGeneral

⋅ 2019년 2월 27일 오전 9시 17분

This isn't an idea. You literally just typed some stuff, did no TA, and hit publish.